| 000 | 01472 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512022653.0 | ||
| 264 | 0 | _c19850131 | |
| 008 | 198501s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(85)90966-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRose, C | |
| 245 | 0 | 0 |
_aBeneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJan 1985 |
||
| 300 |
_a16-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xanalysis |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMenopause |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aTamoxifen _xtherapeutic use |
| 700 | 1 | _aThorpe, S M | |
| 700 | 1 | _aAndersen, K W | |
| 700 | 1 | _aPedersen, B V | |
| 700 | 1 | _aMouridsen, H T | |
| 700 | 1 | _aBlichert-Toft, M | |
| 700 | 1 | _aRasmussen, B B | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8419 _gp. 16-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(85)90966-3 _zAvailable from publisher's website |
| 999 |
_c2862795 _d2862795 |
||